Develops engineered T cell therapies using AI-powered protein design to enhance immune cell functionality for more effective cancer treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Outpace Bio is pioneering advancements in cell therapy by leveraging AI-powered protein design to program immune cells for enhanced functionality within patients. Their innovative approach addresses key challenges in treating solid tumors, such as improving tumor access, cell survival, and immune response. By creating modular, plug-and-play protein assets, the company develops engineered T cell therapies aimed at achieving unprecedented efficacy in combating cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Outpace Bio Management Team
Outpace Bio Valuations & Financials
View real-time NPM data on Outpace Bio stock including daily Outpace Bio stock price estimates, valuation history, and historical share price information. Access Outpace Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Outpace Bio pricing across six independent market signals. Looking for private company due diligence data sources on Outpace Bio? Get in touch to learn more.
Similar Companies
like Outpace Bio
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Ro
Healthcare & Life Sciences
Healthcare technology for a patient-centric healthcare system.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Somatus
Healthcare & Life Sciences
Integrated care for patients with or at risk of developing kidney disease.
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
FAQ
We have answers
Outpace Bio stock does not trade on public stock exchanges. Outpace Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Outpace Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Outpace Bio Stock does not trade on public stock exchanges. In order to sell Outpace Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Outpace Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Outpace Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Outpace Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Outpace Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Outpace Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Outpace Bio is a private company and has not had an IPO. There is currently no Outpace Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Outpace Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
